National Institute of Cardiology, Warsaw, Poland
4 clinical trials · 4 recruiting · OTHER
Trials by National Institute of Cardiology, Warsaw, Poland
RECRUITINGPhase 4NCT07254572
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
The purpose of the study is to compare the anti-atherosclerotic efficacy of oral treatment with a GLP-1 analogue (semaglutide) or an SGLT-2 (so-called "flozin") inhibitor...
Sponsor: National Institute of Cardiology, Warsaw, PolandEnrolling: 3001 location
Coronary Artery DiseasePreDiabetes
RECRUITINGPhase 4NCT03445949
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure
SAFE-LAAC Trial has been designed to gather data on the most optimal strategy of antiplatelet therapy after transcatheter left atrial appendage occlusion with Amplatzer or...
Sponsor: National Institute of Cardiology, Warsaw, PolandEnrolling: 2001 location
Atrial Fibrillation
RECRUITINGPhase 4NCT05660811
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
SAFE-LAAC CKD Trial has been designed to gather data on the most optimal strategy of antiplatelet therapy after transcatheter left atrial appendage occlusion with Amplatzer or...
Sponsor: National Institute of Cardiology, Warsaw, PolandEnrolling: 801 location
Atrial Fibrillation
RECRUITINGNCT07144189
AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography
The purpose of this study is to evaluate the effectiveness of an artificial intelligence (AI) model developed by the investigators for identifying severe low-gradient aortic valve...
Sponsor: National Institute of Cardiology, Warsaw, PolandEnrolling: 3001 location
Low-gradient Aortic StenosisAortic Stenosis